Invariably mesothelioma is diagnosed late in the development of the disease when treatment is no longer effective. Therefore, a key to reducing the mortality rate of this neoplasm is knowledge of the general sequence of genetic events between initiation of mesothelial cells and the emergence of the metastatic tumor cells. Unfortunately, relatively little is known about the early changes in the genesis of this disease. Of the known changes, the most frequent are in the tumor-suppressor genes p 161NK4 and NF2 and possibly the SV40 virus large T-antigen oncogene.
Molecular Pathways of Growth Control
Progression of eukaryotic cells through their cell cyde is regulated by the sequential formation, activation, and inactivation ofa series of cyclin/cydlin-dependent kinase (CDK) complexes. In addition to positive regulation by the activation of cyclin/CDK complexes, negative regulation of the cell cycle occurs through cyclin-dependent kinase inhibitors (CKIs) to prevent premature entry into the next phase of the cyde before completion of necesay macromolecular reactions (1) (2) (3) .
Cell replication begins at the restriction point (R Figure 1) , where growth and arrest signals from the extracellular environment are integrated to determine whether the cell divides or remains quiescent (1) (2) (3) . For example, elevated expression of plateletderived growth factor (PDGF), which is a hallmark of mesothelioma, can elevate the concentration of c-myc in the nudeus. c-myc then induces the expression of cyclin Ds, and the balance between cycin D/CDK4 and its CKI is tipped toward more rapid cell division (3) . Once a growth-positive balance of these factors has developed, the cell is committed to traverse the cell cyde.
In the first phase (Gi), different species of cydin D (DI, D2, D3) are expressed and form complexes with CDK4 and CDK6 (1, 2, 4) . The activated cyclin/CDK complexes phosphorylate the retinoblastoma (Rb) gene product and its related proteins (pI07, p130). When these proteins are hypophosphorylated, they are complexes with transcription factors, e.g., E2F; hyperphosphorylation of the Rb protein releases these transcription factors (1, 2, (4) (5) (6) , which then stimulate the transcription of mRNAs that encode proteins required for the cell to progress further through the cell cycle (1, 2, 4, 5) . The next complex, cyclin E/CDK2, further phosphorylates Rb family proteins, and the cell begins to synthesize DNA. Once the cell enters S phase, i.e., begins to synthesize DNA, a complex between cyclin A and CDK2 kinase forms. This complex, whose role is unclear, is degraded as the cell enters the G2 phase. Finally, the cyclin B/CDC2 complex phosphorylates proteins involved in chromosome condensation and the progression of the cell through mitosis, e.g., HI histone, nuclear lamins, nudeolin, and intermediate filaments (1, 2) .
Two checkpoints in the cell cyde provide the cell with opportunities to govern its rate of cycling. The first, which is at the G1/S border, employs proteins denoted as CKIs. Currently, two structurally defined classes are known. The first, exemplified by pl6INK4a and pi5INK4b and induding p19 and p18, primarily regulates CDK4 and CDK6 (7, 8) by binding to the associated cydins (9) . The second family, characterized by 21cip1, and including p27KIPl and p57KP2, regulates the activities of the CDK2 and CDK4/6 complexes (1,2,4). As will be discussed later, aberrations in the G1/S checkpoint function are associated with mesothelioma. Inhibitor proteins that prevent the activation of the cyclin B/CDC2 complex at the G2/M checkpoint also have been described (1, 2) , but no correlations between these proteins and fiber-caused carcinogenesis have been reported. However, because disruption of mitotic processes is a salient feature of cell-fiber interactions (10) (11) (12) (13) (14) , examining mesothelioma cells for aberrations of the G2/M checkpoint genes may identify one or more that are highly correlated with mesothelioma.
Expression of CKI genes is stimulated by stress factors. For example, damaged DNA initiates events that cause the p53 gene product to accumulate within the cell nucleus (15, 16) . This protein induces the transcription of certain genes while inhibiting others. Two major regulatory proteins induced by the accumulation of p53 are the kinase inhibitor p2lCiPl and the protooncogene mdm2 (15) . The ability of p53 to arrest cell growth can be explained in part by its ability to induce the kinase inhibitor p21CiPl, which inhibits the action of the G 1 phase cyclin-CDK complexes (1) (40) showed that 85% of the mesothelial cell lines they investigated had a homozygous deletion of p16INK4a. However, only 22% of the primary tumors showed this deletion. In contrast, Xiao and co-workers (39) implying that the loss of these genes was a late event (41) . On the other hand, a primary consequence of asbestos exposure is extensive chromosome alterations (11, 24) . Thus, it is also possible that these genes were deleted as a direct result of a fiber interacting with chromatin or spindle proteins (43) . In human lung tumor cells, loss of pl6INK4a is inversely related to retaining the Rb tumor-suppressor gene, and vice versa (41) . Mesotheliomas follow this rule as well; three studies have shown that Rb is not deleted in these tumors (44) (45) (46) (22, 24) . These data on human mesothelioma contrast with murine data where frequent (76%) rearrangement of the gene was found and p53 mRNA expression was frequently reduced or absent (49) . p53 overexpression in the nucleus often reflects abnormal p53 function (15 oncogene. The latter mechanism is supported by Segers et al. (52) ; 60% of the p53 immunopositive but nonmutated tumors they evaluated also overexpressed the p53-inactivating oncogene mdm2. However, Ungar et al. (53) recently reported that mdm2 was not overexpressed in the 17 mesothelioma cell lines they analyzed.
A second p53-inactivating mechanism could be the expression of the T-antigen (T-ag) of the SV40 virus. In cells that have been infected, the p53 protein apparently is overexpressed because it is complexed with large T-ag. This virus causes mesotheliomas when injected into the pleural space of hamsters (54) . Further, Carbone et al. (55) recovered fragments of SV40-like DNA sequences from 60% of the mesotheliomas they examined by polymerase chain reaction (PCR). In addition, 79% of the tumors exhibited SV40 T-ag when assessed using immunohistochemistry, and there was a high correlation between T-ag immunoreactivity and the presence of SV40 sequences. Subsequently, Cristaudo et al. (56) found the same SV40-like DNA sequences in 72% of the mesotheliomas they investigated. In contrast, Metcalf et al. (48) found no evidence of SV40 T-ag in any of the 20 mesothelioma cell lines they investigated using immunohistochemistry. Further conflicting information, however, is in the recent report by Galateau-Salle et al. (57) . These authors showed that SV40-like sequences are found not only in some mesotheliomas but also in pleural plaques, lung tumors, parenchyma distal to the tumors, and in parenchyma of individuals without cancer.
The NF2 autosomal dominant tumorsuppressor gene resides on chromosome 22 (58) . As noted above, this chromosome frequently is abnormal in mesotheliomas (24) . Consequently, this gene has been evaluated in several cell lines. The results show that frameshift and nonsense mutations, and deletions of small portions of the NF2 gene were often present in cell lines (58, 59) . These aberrations also have been found frequently in primary mesotheliomas (59), but they are rare in human lung carcinomas (59) . NF2 codes for a protein called merlin, which may play a role in cell surface dynamics and structure by linking the cytoskeleton to the plasma membrane (58) . Asbestos fibers are known to be more efficient in deforming the cytoskeleton in mesothelial cells than in airway epithelial cells (10) . Thus, loss of stabilizing function supplied by a normal NF2 gene product may be involved in the mechanism of fiber-caused transformation of the mesothelial cell.
A small percentage of mesotheliomas exhibit a cytogenic aberration-an interstitial deletion of bands 1ipl1 to l 1pl3 (24) , where the transcription factor tumor suppressor gene WTI resides (60) Metcalf et al. (48) found no activating mutations of the K-ras oncogene in the 20 mesothelioma cell lines they examined. Further, Lee et al. (68) reported that overexpression of ras protein is a rare event for mesotheliomas. More recently, however, Kishimoto (66) did find frequent immunostaining of N-ras, and Ramael et al. (69) found that more than 50% of the cells within 78% of the mesotheliomas they evaluated had immunoreactivity to N-ras antibody. Notably, N-ras is located on chromosome 1 which is often polysomic in mesotheliomas. Finally, sustained expressions of c-jun and c-fos is induced by fibers (70) , and c-myc, along with c-neu were found to be overexpressed in the majority of the mesotheliomas of Japanese patients (66) .
Many exogenous peptides increase the growth rate of mesothelial cells (71) (72) (73) (74) , and mesothelioma cells produce several growth factors and cytokines (71, (75) (76) (77) (78) (79) . Oncogenes often cause inappropriate expression of growth factors and/or their receptors. As a consequence, normal growth control mechanisms are abrogated. Oncogenes causing the production of growth factors that simulate autoreplication are referred to as autocrines (80) . Autocrine activity, shown not to be PDGF, TGF-,, or EGF, has been detected in the conditioned medium of a mesothelioma cell line; however, the actual factor has not been identified (81) . Nonetheless, repeatedly observed alterations in the expression of PDGF proteins and the associated PDGF receptors by mesotheliomas have suggested that this ligand and receptor produce an autocrine loop in many mesotheliomas (77, 82) . Several laboratories have examined this possibility, with somewhat conflicting and puzzling results.
PDGF-A-protein and PDGF-B-protein chains dimerize to form three species of PDGF that are each mitogenic for mesothelioma cells. One is A-chain homodimers and one is B-chain homodimers; the third is an A/B-chain heterodimer. The PDGF-A chain and PDGF-B chains are coded by separate genes, as are the two receptor proteins, a and 3 (83) . The A/B-chain heterodimer and the B-chain homodimer are recognized by the 3 receptor. All three forms of PDGF bind the a receptor, although with differing affinities. Therefore, alterations in any of four different genes could affect growth of mesothelial cells. Normal mesothelial cells express the a and j receptors (82) (83) (84) (85) (86) (87) (88) (89) . Mesotheliomas often overproduce PDGF A-chain and B-chain proteins and low levels, if any, of the ,B receptor. Therefore, the PDGF-B-chain protein produced by the mesotheliomas may serve as an autocrine for continuous Environmental Health Perspectives * Vol 105, Supplement 5 * September 1997 replication of the tumor cells (82, 85, 89) . However, mesothelioma cells also express the PDGF-A-chain growth factor, and the a receptor has been detected using RNase protection assays and recently by run-off analyses (83) . In addition, transfection experiments with the immortal but nontumorigenic human mesothelial cell MeT-5A have shown that overexpression of the PDGF-A chain will transform these cells to the tumorigenic phenotype (90, 91) . Further, it has been shown using antisense oligonucleotides that the PDGF-A chain, but not the PDGF-B chain, will inhibit the growth of mesothelioma cell lines but not the MeT-5A cells (84 (24) . Therefore, a key to reducing the mortality rate of this disease is knowledge of the general sequence of genetic events that transpire between initiation of mesothelial cells and the emergence of the metastatic tumor cells. As with all tumor systems, but especially for mesothelioma, considerable work remains to be done to clarify which genetic changes are the most important in transformation of the normal cell. The ultimate resolution of these changes will permit the designing of antitumor treatment approaches that could reverse the effects of the altered genes. Future work will require confirmation of the proposed model (Figure 2 ), clarifying the role of the above discussed genetic changes, and elucidating the importance of as yet uninvestigated mechanisms, e.g., the induction ofgenomic instability (96, 97) , reduced DNA repair capacity (96) , disruption of programmed cell death (98) , and inherent susceptibility (99) .
